1.Prevalence and treatment of pediatric dyslipidemia
Kyungchul SONG ; Ho-Seong KIM ; Hyun Wook CHAE
Journal of the Korean Medical Association 2021;64(6):410-415
As dyslipidemia at a young age is a risk factor for cardiovascular disease in adulthood, the screening and management of dyslipidemia in children and adolescents might be an important health issue. This review deals with issues related to the prevalence, diagnosis, screening, and treatment of pediatric dyslipidemia.Current Concepts: In Korea, the prevalence of pediatric dyslipidemia was 19.7% between 2007 and 2009. Dyslipidemia was defined according to the guidelines of the Korean Society of Pediatric Endocrinology: total cholesterol ≥200 mg/dL, low-density lipoprotein cholesterol ≥130 mg/dL, triglycerides ≥130 mg/dL, high-density lipoprotein cholesterol <40 mg/dL, or non-high-density lipoprotein cholesterol ≥145 mg/dL.Discussion and Conclusion: We recommend universal screening tests for dyslipidemia at ages 9–11 years and 17–21 years. Diet and lifestyle modifications are essential in the treatment of dyslipidemia. In children aged ≥10 years with a poor response to lifestyle modification, drug therapy is recommended. Pediatric dyslipidemia should be diagnosed and treated properly to reduce adult cardiovascular diseases and improve quality of life in this age group.
2.Prevalence and treatment of pediatric dyslipidemia
Kyungchul SONG ; Ho-Seong KIM ; Hyun Wook CHAE
Journal of the Korean Medical Association 2021;64(6):410-415
As dyslipidemia at a young age is a risk factor for cardiovascular disease in adulthood, the screening and management of dyslipidemia in children and adolescents might be an important health issue. This review deals with issues related to the prevalence, diagnosis, screening, and treatment of pediatric dyslipidemia.Current Concepts: In Korea, the prevalence of pediatric dyslipidemia was 19.7% between 2007 and 2009. Dyslipidemia was defined according to the guidelines of the Korean Society of Pediatric Endocrinology: total cholesterol ≥200 mg/dL, low-density lipoprotein cholesterol ≥130 mg/dL, triglycerides ≥130 mg/dL, high-density lipoprotein cholesterol <40 mg/dL, or non-high-density lipoprotein cholesterol ≥145 mg/dL.Discussion and Conclusion: We recommend universal screening tests for dyslipidemia at ages 9–11 years and 17–21 years. Diet and lifestyle modifications are essential in the treatment of dyslipidemia. In children aged ≥10 years with a poor response to lifestyle modification, drug therapy is recommended. Pediatric dyslipidemia should be diagnosed and treated properly to reduce adult cardiovascular diseases and improve quality of life in this age group.
3.Exercise-Induced Atrial Fibrillation.
Chae Man LIM ; Jae Joong KIM ; Seung Jung PARK ; Seong Wook PARK ; In Whan SEONG ; Jong Koo LEE
Korean Circulation Journal 1990;20(3):411-417
Two cases of exercise-induced atrial fibrillation were diagnosed in 68 years old female and 47 years old male. They complained palpitation during exercise, and emotional upset for the last 5 years. There was no evidence of organic heart disease except mild hypertension in female patient. The atrial fibrillation was induced repeatedly by treadmill exercise test and intravenous infusion of isoproterenol. The beta blocker(atenolol 50mg po dialy) prevented the induction of atrial fibrillation during treadmill exercise. We report two cases of exercise-induced atrial fibrillation which is very rare and might be related to catecholamine.
Aged
;
Atrial Fibrillation*
;
Exercise Test
;
Female
;
Heart Diseases
;
Humans
;
Hypertension
;
Infusions, Intravenous
;
Isoproterenol
;
Male
;
Middle Aged
4.Coronary Angioplasty in Patients with Multivessel Coronary Artery Disease.
Seung Jung PARK ; Seong Wook PARK ; Jae Jeong KIM ; In Whan SEONG ; Jae Kwan SONG ; Chae Man LIM ; Jong Koo LEE
Korean Circulation Journal 1991;21(3):587-597
To assess the likelihood of procedural success in patients with multivessel coronary artery disease, 46 consecutive patients (male 34, female 12, mean age 60+/-9 years) umderwent single or multiple site angioplasty. The clinical diagnosis of unstable angina was in 20(44%), stable angina in 10 and acute or old myocardial infarction in 16. Coronary angiographic findings of 2 vessel disease was in 38(83%), triple vessel disease in 8. Left ventricular function was generally well preserved (mean ejection fraction 65+/-12%, range 30-82%) and mean 2.0 stenosis per patient angic, lasty had attempted. Single vessel angioplasty (SVA) was performed in 13 and multivessel angioplasty (MVA) in 33. Procedural success was achieved in 79(86%) out of total 92 stenoses. Sixty-six(88%) out of 75 stenoses in MVA and 13(76%) out of 17 stenoses in SVA had procedural success respectively. According to angiographic morphology of lesions, procedural success of type A stenoses was 17/17(100%), type B stenoses 57/66(86%) and type C stenoses was 5/9(33%). In 13 failures included inability to pass the guide wire cross the lesion in 7, inability to guide the griding catheter in 2 and inability to dilate lesions in 4. Before and after angioplasty, treadmill test (modified Bruce protocol)could be performed in 29 patients. Total duration of exercise and maximal double product improved significantly from 8.5+/-2.3 minute 5188+/-2403 to 12.2+1.3 min., 23,062+/-4111 respectively (p<0.001). 17 out of 24 patients who had positive treadmill test before angioplasty showed negative conversion after procedure. Complications included dissection in 29, prolongd chest pain in 5, acute closure in 3, cardiac tamponade in 1 and ventricular fibrillation due to side branch oclusion in 1. Thus, coronary angioplasty in selected paients with multivessel coronary artery disease might be useful and have relatively good immediate results, but the long-term efficacies with other forms of treatment must be evaluated prospectively.
Angina, Stable
;
Angina, Unstable
;
Angioplasty*
;
Cardiac Tamponade
;
Catheters
;
Chest Pain
;
Constriction, Pathologic
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Diagnosis
;
Exercise Test
;
Female
;
Humans
;
Myocardial Infarction
;
Ventricular Fibrillation
;
Ventricular Function, Left
5.Posttraumatic Stress Disorder Among Occupational Accident Patients.
Kyeong Sook CHOI ; Chae Ki LIM ; Jae Wook CHOI ; Seong Kyu KANG ; Yong Tae YUM
Journal of Korean Neuropsychiatric Association 2002;41(3):461-471
OBJECTIVES: This study was conducted to assess the development of posttraumatic stress disorder (PTSD) after occupational physical injuries and the risk factors in occupational accident patients for PTSD. METHODS: Forty-seven occupational accident patients with physical injuries were administered BDI, STAI I and II, SCL-90-R, IES and questionnaires for risk factors and Clinician-Administered PTSD Scale(CAPS). RESULTS: 1) 12 patients(25%) were diagnosed as PTSD. 2) The BDI, STAI I and II and IES scores are significantly high(<0.05) in PTSD group than non-PTSD group. 3) The subscales of SCL-90-R, with an exception of PAR subscale, showed higher scores(<0.05) in PTSD group. 4) The loss of consciousness(LOC) was only significant risk factor in the occupational accident-related factors(<0.05). CONCLUSION: The results of this study show the development of PTSD among occupational accident patients. The loss of consciousness(LOC) was the only signiticant risk factor for PTSD in occupational accident patients.
Accidents, Occupational*
;
Humans
;
Surveys and Questionnaires
;
Risk Factors
;
Stress Disorders, Post-Traumatic*
6.A Case of Deflation Failure of Inoue Balloon.
Seung Jung PARK ; Seong Wook PARK ; Jae Joong KIM ; Chae Man LIM ; Sang We KIM ; Jong Koo LEE
Korean Circulation Journal 1990;20(2):256-259
We have experienced a case of deflation failure of Inoue balloon in the left atrium during mitral balloon valvuloplasty in a 44 year old male patient with tight mitral stenosis, who died just after emergency open heart surgery for removal of undeflated Inoue balloon and mitral valve replacement because of associated acute hemorrhagic myocardial infarction.
Adult
;
Balloon Valvuloplasty
;
Emergencies
;
Heart Atria
;
Humans
;
Male
;
Mitral Valve
;
Mitral Valve Stenosis
;
Myocardial Infarction
;
Thoracic Surgery
7.Diagnosis and Treatment of Central Precocious Puberty
Han Saem CHOI ; Ho-Seong KIM ; Hyun Wook CHAE
The Ewha Medical Journal 2021;44(4):117-121
A notable secular trend in early puberty onset has been described over the past few decades. Also, the prevalence and incidence of precocious puberty is increasing not only in Korea, but also around the world. The manifestation of secondary sex characteristics before 8 years in girls and 9 years in boys is defined as precious puberty. The causes of precocious puberty can be classified as gonadotropin releasing hormone (GnRH)-dependent, also known as central precocious puberty (CPP), or GnRH-independent. Evaluation of patient with precocity requires detailed examination of the clinical manifestation, GnRH stimulation test, and imaging of the central nervous system if indicated. The standard treatment for CPP is GnRH agonist, which is beneficial for adequate pubertal development and preservation of final adult height. In this paper, we investigate the diagnosis and adequate treatment of CPP.
8.Recurrence of Brain Tumors in Patients Treated with Growth Hormone.
Duk Hee KIM ; Hyun Wook CHAE ; Mi Yung KWON ; Ho Seong KIM
Journal of Korean Society of Pediatric Endocrinology 2007;12(2):99-103
PURPOSE: Growth hormone (GH) has been used successfully in the treatment of short stature secondary to GH deficiency in survivors of childhood brain tumors. There has been concerned that GH might increase the risk of tumor recurrence in spite of improvement of growth. METHODS: Data for tumor recurrence from 1997 to 2006 were analysed retrospectively in 56 patients with craniopharyngioma, 78 patients with medulloblastomas, 14 patients with germinomas and 139 patients with astrocytomas or gliomas after GH treatment. Serum insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-3 were measured. RESULTS: 57 GH deficient and growth retarded patients (17.4%) were treated with recombinant human GH and followed up 60 months after starting GH treatment. 6 patients (10.5%) (5 craniopharyngioma, 1 germinoma) were recurred among patients with GH therapy, but 17 patients (5.2%) were recurred among patients with non GH therapy. Tumor recurrence in GH treated group was not higher than in non GH treated group. There was no significant change in serum IGF-1, IGFBP-3 level and IGF-1/IGFBP-3 ratio. CONCLUSION: Tumor recurrence rates in surviving patients with brain tumors receiving GH treatment do not appear to be increased compared with non GH treatment. However, longer follow-up regarding recurrences and secondary neoplasms remains to be essential.
Astrocytoma
;
Brain Neoplasms*
;
Brain*
;
Carrier Proteins
;
Craniopharyngioma
;
Follow-Up Studies
;
Germinoma
;
Glioma
;
Growth Hormone*
;
Humans
;
Insulin-Like Growth Factor Binding Protein 3
;
Insulin-Like Growth Factor I
;
Medulloblastoma
;
Recurrence*
;
Retrospective Studies
;
Survivors
9.Effects of Myocardial Stunning on Remote Coronary Flow Reserve.
Keon Woong MOON ; Jae Hyung KIM ; Ki Dong YOO ; Ho Joong YOUN ; Wook Sung CHUNG ; Jang Seong CHAE ; Kyu Bo CHOI ; Soon Jo HONG
Korean Circulation Journal 1998;28(12):2002-2010
BACKGROUND: In patients with myocardial infarction (MI) and chronic stable angina, the coronary flow reserve (CFR) is reduced not only in the region of myocardium perfused by the ischemia-related artery but also in the regions supplied by angiographically normal coronary arteries. The effect of myocardial stunning on the remote CFR is unknown, however. METHODS: In ten open-chest anesthetized dogs, left circumflex coronary artery was occluded for 15 minutes (myocardial stunning group, n=5) or for 30 minutes (MI group, n=5) and was followed by a reperfusion for 60 minutes. Before coronary occlusion and at 30 minutes and at 60 minutes after reperfusion, resting coronary blood flow (CBF) and maximal CBF after IV injection of each of adenosine (ADE) and acetylcholine (Ach) was measured with electromagnetic flow probe located in the proximal left anterior descending coronary artery. CFR was calculated as the ratio of maximal and resting CBF. RESULTS: At 30 minutes and 60 minutes after reperfusion, the remote resting CBF were significantly increased in both groups and the remote CFR was significantly decreased in both groups. The CFR of the MI group was lower than myocardial stunning group. The coronary vasodilator response to Ach was significantly lower than the response to ADE in both groups. CONCLUSION: After MI and myocardial stunning, there was severe coronary vasodilator abnormality in the remote myocardium and that was more marked after MI. The coronary vasodilator response to Ach was significantly lower than the response to ADE in both groups, suggesting endothelial dysfunction in remote myocardium.
Acetylcholine
;
Adenosine
;
Angina, Stable
;
Animals
;
Arteries
;
Coronary Occlusion
;
Coronary Vessels
;
Dogs
;
Humans
;
Magnets
;
Myocardial Infarction
;
Myocardial Stunning*
;
Myocardium
;
Reperfusion
10.The Clinical Measures Associated with C-peptide Decline in Patients with Type 1 Diabetes over 15 Years.
Tae Ho LEE ; Ah Reum KWON ; Ye Jin KIM ; Hyun Wook CHAE ; Ho Seong KIM ; Duk Hee KIM
Journal of Korean Medical Science 2013;28(9):1340-1344
This study was done to characterize the natural course of C-peptide levels in patients with type 1 diabetes and identify distinguishing characters among patients with lower rates of C-peptide decline. A sample of 95 children with type 1 diabetes was analyzed to retrospectively track serum levels of C-peptide, HbA1c, weight, BMI, and diabetic complications for the 15 yr after diagnosis. The clinical characteristics were compared between the patients with low and high C-peptide levels, respectively. The average C-peptide level among all patients was significantly reduced five years after diagnosis (P < 0.001). The incidence of diabetic ketoacidosis was significantly lower among the patients with high levels of C-peptide (P = 0.038). The body weight and BMI standard deviation scores (SDS) 15 yr after diagnosis were significantly higher among the patients with low C-peptide levels (weight SDS, P = 0.012; BMI SDS, P = 0.044). In conclusion, C-peptide level was significantly decreased after 5 yr from diagnosis. Type 1 diabetes patients whose beta-cell functions were preserved might have low incidence of diabetic ketoacidosis. The declines of C-peptide level after diagnosis in type 1 diabetes may be associated with changes of body weight and BMI.
Adolescent
;
Body Mass Index
;
Body Weight
;
C-Peptide/*blood
;
Child
;
Child, Preschool
;
Diabetes Complications
;
Diabetes Mellitus, Type 1/blood/*diagnosis
;
Diabetic Ketoacidosis/epidemiology
;
Diabetic Retinopathy/epidemiology
;
Female
;
Follow-Up Studies
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
Incidence
;
Infant
;
Male
;
Peripheral Nervous System Diseases/epidemiology
;
Retrospective Studies